Get the Stockscreener App
3.58
2.87%
+0.10
ARCA biopharma Inc Stock (ABIO) Forecast
The ARCA biopharma Inc (ABIO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $9.059, representing a +153.04% increase from the current price of $3.58. The highest analyst price target is $16.77, and the lowest is $1.3511.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ABIO Price Target
Average 8.452
(+136.09% Upside)
Is ARCA biopharma Inc (ABIO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 75.67 | Sell |
| STOCH(9,6) | 80.80 | Sell |
| STOCHRSI(14) | 18.46 | Buy |
| MACD(12,26) | 0.3984 | Buy |
| ADX(14) | 66.31 | Buy |
| William %R | -22.08 | Neutral |
| CCI(14) | 105.30 | Buy |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.41
Buy
|
3.4036
Buy
|
| MA20 |
3.1385
Buy
|
3.1048
Buy
|
| MA50 |
2.2664
Buy
|
2.5348
Buy
|
| MA100 |
1.9739
Buy
|
2.2134
Buy
|
| MA200 |
1.9798
Buy
|
2.0803
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ABIO could be considered a Strong Buy, with 17 technical analysis indicators signaling 14 Buy signals, 2 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on ABIO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 75.67 indicates that ABIO is overbought. This suggests that ABIO price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 80.8 indicates that ABIO is oversold. This means that ABIO price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 18.46 indicates that ABIO is oversold. This suggests that ABIO price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 66.31 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 105.3 indicates that ABIO is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ABIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about ARCA biopharma Inc financial reports and earnings history, ARCA biopharma Inc (ABIO) stock could reach $13.10 by 2030, $2.6654 by 2040 and $9.1859 by 2050. See the projected annual prices until 2050 of the ARCA biopharma Inc stock below:
- ARCA biopharma Inc (ABIO) is expected to reach an average price of $0.7021 in 2035, with a high prediction of $0.5949 and a low estimate of $0.5903. This indicates an $-80.39% rise from the last recorded price of $3.58.
- ARCA biopharma Inc (ABIO) stock is projected to chart a bullish course in 2040, with an average price target of $2.7062, representing an $-24.41% surge from its current level. The forecast ranges from a conservative $2.7208 to a sky-high $2.6654.
- Our analysts predict ARCA biopharma Inc (ABIO) to jump 47.46% by 2045, soaring from $5.319 to an average price of $5.279, potentially reaching $5.2946. While $5.319 is the low estimate, the potential upside is significant.
- ARCA biopharma Inc (ABIO) stock is expected to climb by 2050, reaching an average of $9.2104, a $157.27% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.1859 and $9.2704, respectively, highlighting the market's uncertainty.
ARCA biopharma Inc Stock (ABIO) Year by Year Forecast
ARCA biopharma Inc Stock (ABIO) Price Forecast for 2024
Our forecast for ABIO stock price in 2024 now indicates an average price target of $9.059 with a high forecast of $16.77 and a low forecast of $1.3511. The average prediction reflects an increase of +153.04% from the last recorded price of $3.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $7.3002 | $1.3511 | $16.77 | +103.92% |
| June, 2024 | $2.1866 | $2.1216 | $12.93 | -38.92% |
| July, 2024 | $3.4321 | $1.9512 | $5.2557 | -4.13% |
| August, 2024 | $3.1884 | $3.0484 | $3.9302 | -10.94% |
| September, 2024 | $1.9989 | $1.3748 | $3.3575 | -44.16% |
| October, 2024 | $1.9203 | $1.695 | $3.8883 | -46.36% |
| November, 2024 | $1.8272 | $1.451 | $2.3067 | -48.96% |
| December, 2024 | $1.8022 | $1.554 | $2.6031 | -49.66% |
ARCA biopharma Inc Stock (ABIO) Price Forecast for 2025
ARCA biopharma Inc Stock (ABIO) is expected to reach an average price of $9.5157 in 2025, with a high prediction of $18.89 and a low estimate of $0.1372. This indicates an +165.80% rise from the last recorded price of $3.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.9386 | $1.7304 | $2.6204 | -45.85% |
| February, 2025 | $2.325 | $1.8577 | $2.9068 | -35.06% |
| March, 2025 | $2.2826 | $1.7714 | $3.2036 | -36.24% |
| April, 2025 | $0.5769 | $0.1372 | $2.4726 | -83.89% |
| May, 2025 | $0.4077 | $0.524 | $0.776 | -88.61% |
| June, 2025 | $0.5288 | $0.1377 | $2.2106 | -85.23% |
| July, 2025 | $0.7352 | $0.2479 | $1.057 | -79.46% |
| August, 2025 | $3.7716 | $0.5643 | $18.89 | +5.35% |
| September, 2025 | $4.0271 | $3.0571 | $4.7007 | +12.49% |
| October, 2025 | $2.9435 | $2.8634 | $5.5862 | -17.78% |
| November, 2025 | $1.4498 | $1.0298 | $3.1925 | -59.50% |
| December, 2025 | $1.6553 | $0.9171 | $2.548 | -53.76% |
ARCA biopharma Inc Stock (ABIO) Price Forecast for 2026
The predicted value for ARCA biopharma Inc (ABIO) in 2026 is set at an average of $1.491. Estimates vary from a peak of $2.7673 to a trough of $0.2148, indicating an -58.35% surge from the present price of $3.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9717 | $0.8317 | $2.4943 | -72.86% |
| February, 2026 | $1.4381 | $0.879 | $1.6079 | -59.83% |
| March, 2026 | $1.4536 | $1.1554 | $1.9536 | -59.40% |
| April, 2026 | $1.90 | $1.1728 | $2.08 | -46.93% |
| May, 2026 | $2.0264 | $1.3891 | $2.7673 | -43.40% |
| June, 2026 | $1.0019 | $0.8146 | $2.3855 | -72.01% |
| July, 2026 | $0.7183 | $0.5783 | $1.1526 | -79.94% |
| August, 2026 | $0.7338 | $0.3147 | $1.0665 | -79.50% |
| September, 2026 | $1.0502 | $0.6129 | $1.3402 | -70.67% |
| October, 2026 | $1.1566 | $0.7866 | $1.2266 | -67.69% |
| November, 2026 | $0.4421 | $0.2148 | $1.3439 | -87.65% |
| December, 2026 | $0.6585 | $0.2612 | $0.7283 | -81.61% |
ARCA biopharma Inc Stock (ABIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for ARCA biopharma Inc (ABIO) is $0.3693, with a high forecast of $0.7343 and a low forecast of $0.00417. This indicates an -89.69% decrease from the last price of $3.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.5548 | $0.4068 | $0.7343 | -84.50% |
| February, 2027 | $0.2912 | $0.2721 | $0.5839 | -91.86% |
| March, 2027 | $0.2867 | $0.0485 | $0.5903 | -91.99% |
| April, 2027 | $0.0831 | $0.00417 | $0.2858 | -97.68% |
| May, 2027 | $0.3214 | $0.0328 | $0.2022 | -91.02% |
| June, 2027 | $0.245 | $0.325 | $0.2932 | -93.16% |
| July, 2027 | $0.1286 | $0.1977 | $0.2359 | -96.41% |
| August, 2027 | $0.0769 | $0.0704 | $0.4087 | -97.85% |
| September, 2027 | $0.2833 | $0.046 | $0.4941 | -92.09% |
| October, 2027 | $0.3697 | $0.1524 | $0.3897 | -89.67% |
| November, 2027 | $0.4552 | $0.1861 | $0.5452 | -87.29% |
| December, 2027 | $0.5216 | $0.2843 | $0.5816 | -85.43% |
ARCA biopharma Inc Stock (ABIO) Price Forecast for 2028
In 2028, ARCA biopharma Inc (ABIO) is projected to reach an average price of $0.5203, with a high projection of $0.9862 and a low estimate of $0.0544. This indicates an -85.47% fall from the last price of $3.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4271 | $0.3389 | $0.5421 | -88.07% |
| February, 2028 | $0.4335 | $0.3735 | $0.5097 | -87.89% |
| March, 2028 | $0.2198 | $0.1507 | $0.5317 | -93.86% |
| April, 2028 | $0.3362 | $0.1089 | $0.3812 | -90.61% |
| May, 2028 | $0.3217 | $0.0544 | $0.3853 | -91.01% |
| June, 2028 | $0.6181 | $0.2612 | $0.7281 | -82.73% |
| July, 2028 | $0.5336 | $0.4936 | $0.9862 | -85.09% |
| August, 2028 | $0.47 | $0.3509 | $0.6517 | -86.87% |
| September, 2028 | $0.5664 | $0.4092 | $0.6473 | -84.18% |
| October, 2028 | $0.4339 | $0.3528 | $0.6055 | -87.88% |
| November, 2028 | $0.5283 | $0.3526 | $0.5992 | -85.24% |
| December, 2028 | $0.6147 | $0.4974 | $0.6447 | -82.83% |
ARCA biopharma Inc Stock (ABIO) Price Forecast for 2029
The 2029 price forecast for ARCA biopharma Inc Stock (ABIO) is $4.9793 on average, with a high prediction of $9.902 and a low estimate of $0.0566. This represents an +39.09% increase from the previous price of $3.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6102 | $0.5411 | $0.6829 | -82.96% |
| February, 2029 | $0.6266 | $0.5684 | $0.6493 | -82.50% |
| March, 2029 | $0.673 | $0.6139 | $0.693 | -81.20% |
| April, 2029 | $0.6785 | $0.6221 | $0.7321 | -81.05% |
| May, 2029 | $0.7349 | $0.6867 | $0.7558 | -79.47% |
| June, 2029 | $0.534 | $0.4672 | $0.7639 | -85.08% |
| July, 2029 | $0.5967 | $0.4862 | $0.7185 | -83.33% |
| August, 2029 | $1.7818 | $0.5149 | $1.80 | -50.23% |
| September, 2029 | $0.089 | $0.449 | $0.3054 | -97.51% |
| October, 2029 | $0.722 | $0.2326 | $9.902 | -79.83% |
| November, 2029 | $0.6434 | $0.0566 | $3.8002 | -82.03% |
| December, 2029 | $1.7643 | $0.807 | $1.1425 | -50.72% |
ARCA biopharma Inc Stock (ABIO) Price Forecast for 2030
ARCA biopharma Inc Stock (ABIO) is expected to reach an average price of $6.7012 in 2030, with a high forecast of $13.10 and a low forecast of $0.3054. This signifies an +87.18% surge from the last price of $3.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.8286 | $2.0444 | $13.10 | +62.81% |
| February, 2030 | $0.0113 | $0.5034 | $6.0967 | -99.68% |
| March, 2030 | $0.1559 | $0.3054 | $0.5659 | -95.65% |
| April, 2030 | $0.7949 | $0.4013 | $0.3605 | -77.80% |
| May, 2030 | $1.5071 | $1.2167 | $1.2621 | -57.90% |
| June, 2030 | $1.5493 | $1.4475 | $1.2593 | -56.72% |
| July, 2030 | $1.5184 | $1.7134 | $1.5111 | -57.59% |
| August, 2030 | $1.5856 | $1.7421 | $1.552 | -55.71% |
| September, 2030 | $0.9846 | $1.471 | $1.4074 | -72.50% |
| October, 2030 | $0.3235 | $1.1081 | $0.8782 | -90.96% |
| November, 2030 | $0.9869 | $1.0854 | $0.7572 | -72.43% |
| December, 2030 | $3.738 | $1.2508 | $2.448 | +4.41% |
1.53%
3.38%
Cap:
|
Volume (24h):